| abstract |
The present disclosure generally relates to rapid release pharmaceutical dosage unit tablets containing a drug that is a mitogen-activated protein kinase inhibitor, a filler, and a disintegrant, and methods for forming the same. More specifically, the present disclosure relates to pharmaceutical dosage unit tablets comprising cobicitinib, at least one filler, at least one lubricant, and at least one disintegrant, and for the preparation of granules formed by dry granulation The tablet method. |